Hydrogel for Simultaneous Tunable Growth Factor Delivery and Enhanced Viability of Encapsulated Cells in Vitro

Biomacromolecules

Volumn 17, Issue 2, 2016, Pages 476-484

  Parker, James ^a,b   Mitrousis, Nikolaos ^b,c   Shoichet, Molly S ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDES; BIOCOMPATIBILITY; BIOLOGICAL MATERIALS; CELLS; CYTOLOGY; HYDROGELS; PROTEINS; TISSUE; TISSUE ENGINEERING;

CONTROLLED DELIVERY; ENCAPSULATED CELL; GROWTH FACTOR DELIVERY; INSULIN-LIKE GROWTH FACTOR-1; PROTEIN THERAPEUTICS; RETINAL PIGMENT EPITHELIUM; THERAPEUTIC PROTEIN; TISSUE ENGINEERING APPLICATIONS;

CELL ENGINEERING;

HYALURONIC ACID; HYBRID PROTEIN; METHYLCELLULOSE; PROTEIN SH3; SOMATOMEDIN C; CULTURE MEDIUM; HYDROGEL; IGF1 PROTEIN, HUMAN;

ARTICLE; CELL ENCAPSULATION; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EMBRYO; HUMAN; HUMAN CELL; HYDROGEL; IN VITRO STUDY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN SECRETION; TISSUE ENGINEERING; CELL CULTURE; CELL CULTURE TECHNIQUE; CELL PROLIFERATION; CHEMISTRY; CULTURE MEDIUM; EPITHELIUM CELL; HUMAN EMBRYONIC STEM CELL; PHYSIOLOGY; RETINAL PIGMENT EPITHELIUM;

CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CULTURE MEDIA; EPITHELIAL CELLS; HUMAN EMBRYONIC STEM CELLS; HUMANS; HYDROGELS; INSULIN-LIKE GROWTH FACTOR I; RETINAL PIGMENT EPITHELIUM;

EID: 84957922290     PISSN: 15257797     EISSN: 15264602     Source Type: Journal    
DOI: 10.1021/acs.biomac.5b01366     Document Type: Article

References (79)

1. Schmeer, C. W.; Wohl, S. G.; Isenmann, S. Cell-replacement therapy and neural repair in the retina Cell Tissue Res. 2012, 349 (1) 363-374 10.1007/s00441-012-1335-6
2. Sheffield, W. P. Modification of clearance of therapeutic and potentially therapeutic proteins Curr. Drug Targets: Cardiovasc. & Haematol. Disord. 2001, 1 (1) 1-22 10.2174/1568006013338150
3. El Sanharawi, M.; Kowalczuk, L.; Touchard, E.; Omri, S.; de Kozak, Y.; Behar-Cohen, F. Protein delivery for retinal diseases: From basic considerations to clinical applications Prog. Retinal Eye Res. 2010, 29 (6) 443-465 10.1016/j.preteyeres.2010.04.001
4. Sivasubramanian, M.; Thambi, T.; Park, J. H. Mineralized cyclodextrin nanoparticles for sustained protein delivery Carbohydr. Polym. 2013, 97 (2) 643-649 10.1016/j.carbpol.2013.05.018
5. Vulic, K.; Shoichet, M. S. Affinity-based drug delivery systems for tissue repair and regeneration Biomacromolecules 2014, 15 (11) 3867-3880 10.1021/bm501084u
6. Putney, S.; Burke, P. Improving protein therapeutics with sustained-release formulations Nat. Biotechnol. 1998, 16 (2) 153-157 10.1038/nbt0298-153
7. Vulic, K.; Shoichet, M. S. Tunable growth factor delivery from injectable hydrogels for tissue engineering J. Am. Chem. Soc. 2012, 134 (2) 882-885 10.1021/ja210638x
8. Rao, K.; El-Hami, K.; Kodaki, T.; Matsushige, K.; Makino, K. A novel method for synthesis of silica nanoparticles J. Colloid Interface Sci. 2005, 289 (1) 125-131 10.1016/j.jcis.2005.02.019
9. Yang, H.; Tyagi, P.; Kadam, R. S.; Holden, C. A.; Kompella, U. B. Hybrid dendrimer hydrogel/PLGA nanoparticle platform sustains drug delivery for one week and antiglaucoma effects for four days following one-time topical administration ACS Nano 2012, 6 (9) 7595-7606 10.1021/nn301873v
10. Lu, Y.; Zhou, N.; Huang, X. et al. Effect of intravitreal injection of bevacizumab-chitosan nanoparticles on retina of diabetic rats Int. J. Ophthalmol. 2014, 7 (1) 1-7
11. Akiyama, G.; Sakai, T.; Kuno, N. et al. Photoreceptor rescue of pigment epithelium-derived factor-impregnated nanoparticles in royal college of surgeons rats Mol. Vis. 2012, 18 (314-15) 3079-3086
12. Fu, K.; Klibanov, A. M.; Langer, R. Protein stability in controlled-release systems Nat. Biotechnol. 2000, 18 (1) 24-25 10.1038/71875
13. Colletier, J.; Chaize, B.; Winterhalter, M.; Fournier, D. Protein encapsulation in liposomes: Efficiency depends on interactions between protein and phospholipid bilayer BMC Biotechnol. 2002, 2 (1) 9 10.1186/1472-6750-2-9
14. Pakulska, M. M.; Vulic, K.; Shoichet, M. S. Affinity-based release of chondroitinase ABC from a modified methylcellulose hydrogel J. Controlled Release 2013, 171 (1) 11-16 10.1016/j.jconrel.2013.06.029
15. Vulic, K.; Shoichet, M. S. Affinity-based drug delivery systems for tissue repair and regeneration Biomacromolecules 2014, 15 (11) 3867-3880 10.1021/bm501084u
16. Jeon, O.; Kang, S.; Lim, H.; Chung, J.; Kim, B. Long-term and zero-order release of basic fibroblast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel Biomaterials 2006, 27 (8) 1598-1607 10.1016/j.biomaterials.2005.08.030
17. Ruvinov, E.; Leor, J.; Cohen, S. The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction Biomaterials 2011, 32 (2) 565-578 10.1016/j.biomaterials.2010.08.097
18. Tam, R. Y.; Fuehrmann, T.; Mitrousis, N.; Shoichet, M. S. Regenerative therapies for central nervous system diseases: A biomaterials approach Neuropsychopharmacology 2014, 39 (1) 169-188 10.1038/npp.2013.237
19. Kaplan, H. J.; Tezel, T. H.; Berger, A. S.; Del Priore, L. V. Retinal transplantation. In Immune Response and the Eye; Streilein, J. W., Ed.; Karger: Basel, 1999; pp 207-219.
20. Lester, L. B.; Francis-Pau, K. Y.; Wolf, D. P. Preclinical trials for stem cell therapy. In Stem Cells in Endocrinology; Lester, L. B., Ed.; Humana Press: Totowa, NJ, 2007; p 250.
21. Schwartz, S. D.; Hubschman, J.; Heilwell, G. et al. Embryonic stem cell trials for macular degeneration: A preliminary report Lancet 2012, 379 (9817) 713-720 10.1016/S0140-6736(12)60028-2
22. Ding, X.; Patel, M.; Chan, C. Molecular pathology of age-related macular degeneration Prog. Retinal Eye Res. 2009, 28 (1) 1-18 10.1016/j.preteyeres.2008.10.001
23. Strauss, O. The role of retinal pigment epithelium in visual functions Ophthalmologe 2009, 106 (4) 299-304 10.1007/s00347-008-1869-x
24. Afshari, F. T.; Fawcett, J. W. Improving RPE adhesion to bruch's membrane Eye 2009, 23 (10) 1890-1893 10.1038/eye.2008.411
25. Pan, C. K.; Heilweil, G.; Lanza, R.; Schwartz, S. D. Embryonic stem cells as a treatment for macular degeneration Expert Opin. Biol. Ther. 2013, 13 (8) 1125-1133 10.1517/14712598.2013.793304
26. Afshari, F. T.; Kwok, J. C.; Andrews, M. R. et al. Integrin activation or alpha9 expression allows retinal pigmented epithelial cell adhesion on bruch's membrane in wet age-related macular degeneration Brain 2010, 133, 448-464 10.1093/brain/awp319
27. Heller, J. P.; Martin, K. R. Enhancing RPE cell-based therapy outcomes for AMD: The role of bruch's membrane Transl. Vis. Sci. Technol. 2014, 3 (4) 4 10.1167/tvst.3.4.4
28. Sakai, S.; Liu, Y.; Sengoku, M.; Taya, M. Cell-selective encapsulation in hydrogel sheaths via biospecific identification and biochemical cross-linking Biomaterials 2015, 53, 494-501 10.1016/j.biomaterials.2015.02.119
29. Burdick, J.; Anseth, K. Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogels for bone tissue engineering Biomaterials 2002, 23 (22) 4315-4323 10.1016/S0142-9612(02)00176-X
30. Burdick, J. A.; Prestwich, G. D. Hyaluronic acid hydrogels for biomedical applications Adv. Mater. 2011, 23 (12) H41-H56 10.1002/adma.201003963
31. Mothe, A. J.; Tam, R. Y.; Zahir, T.; Tator, C. H.; Shoichet, M. S. Repair of the injured spinal cord by transplantation of neural stem cells in a hyaluronan-based hydrogel Biomaterials 2013, 34 (15) 3775-3783 10.1016/j.biomaterials.2013.02.002
32. Tam, R. Y.; Cooke, M. J.; Shoichet, M. S. A covalently modified hydrogel blend of hyaluronan-methyl cellulose with peptides and growth factors influences neural stem/progenitor cell fate J. Mater. Chem. 2012, 22, 19402-19411 10.1039/c2jm33680d
33. Baumann, M. D.; Kang, C. E.; Tator, C. H.; Shoichet, M. S. Intrathecal delivery of a polymeric nanocomposite hydrogel after spinal cord injury Biomaterials 2010, 31 (30) 7631-7639 10.1016/j.biomaterials.2010.07.004
34. Gupta, D.; Tator, C. H.; Shoichet, M. S. Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord Biomaterials 2006, 27 (11) 2370-2379 10.1016/j.biomaterials.2005.11.015
35. Shoichet, M. S.; Tator, C. H.; Poon, P.; Kang, K.; Baumann, M. D. Intrathecal drug delivery strategy is safe and efficacious for localized delivery to the spinal cord Prog. Brain Res. 2007, 161, 385-92 10.1016/S0079-6123(06)61027-3
36. Ballios, B. G.; Cooke, M. J.; van der Kooy, D.; Shoichet, M. S. A hydrogel-based stem cell delivery system to treat retinal degenerative diseases Biomaterials 2010, 31 (9) 2555-2564 10.1016/j.biomaterials.2009.12.004
37. Ballios, B.; Cooke, M.; Donaldson, L. A hyaluronan-based injectable hydrogel improves the survival and integration of stem cell progeny following transplantation Stem Cell Rep. 2015, 4 (6) 1031-1045 10.1016/j.stemcr.2015.04.008
38. Beriat, G. K.; Akmansu, S. H.; Dogan, C. et al. The effect of subcutaneous insulin-like growth factor-1 (IGF-1) injection on rabbit auricular cartilage autograft viability Bosnian J. Basic Med. Sci. 2012, 12 (4) 213-218
39. Dai, W.; Kloner, R. A. Cardioprotection of insulin-like growth factor-1 during reperfusion therapy what is the underlying mechanism or mechanisms? Circ.: Cardiovasc. Interventions 2011, 4 (4) 311-313 10.1161/CIRCINTERVENTIONS.111.964049
40. Seigel, G.; Chiu, L.; Paxhia, A. Inhibition of neuroretinal cell death by insulin-like growth factor-1 and its analogs Mol. Vis. 2000, 6 (19) 157-163
41. Seigel, G. M.; Lupien, S. B.; Campbell, L. A.; Ishii, D. N. Systemic IGF-I treatment inhibits cell death in diabetic rat retina J. Diabetes Complications 2006, 20 (3) 196-204 10.1016/j.jdiacomp.2005.06.007
42. ZAPF, J.; FROESCH, E. Insulin-like growth-factors somatomedins-structure, secretion, biological actions and physiological-role Horm. Res. 1986, 24 (2-3) 121-130 10.1159/000180551
43. Sherrard, R.; Bower, A. Role of afferents in the development and cell survival of the vertebrate nervous system Clin. Exp. Pharmacol. Physiol. 1998, 25 (7-8) 487-495 10.1111/j.1440-1681.1998.tb02241.x
44. Valenciano, A. I.; Boya, P.; de la Rosa, E. J. Early neural cell death: Numbers and cues from the developing neuroretina Int. J. Dev. Biol. 2009, 53 (8-10) 1515-1528 10.1387/ijdb.072446av
45. West, E. L.; Pearson, R. A.; Duran, Y. et al. Manipulation of the recipient retinal environment by ectopic expression of neurotrophic growth factors can improve transplanted photoreceptor integration and survival Cell Transplant. 2012, 21 (5) 871-887 10.3727/096368911X623871
46. GRANT, M.; GUAY, C.; MARSH, R. Insulin-like growth factor-i stimulates proliferation, migration, and plasminogen-activator release by human retinal-pigment epithelial-cells Curr. Eye Res. 1990, 9 (4) 323-335 10.3109/02713689008999620
47. Peruzzi, F.; Prisco, M.; Dews, M. et al. Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis Mol. Cell. Biol. 1999, 19 (10) 7203-7215 10.1128/MCB.19.10.7203
48. Parrizas, M.; Saltiel, A.; LeRoith, D. Insulin-like growth factor 1 inhibits apoptosis using the phosphatidylinositol 3'-kinase and mitogen-activated protein kinase pathways J. Biol. Chem. 1997, 272 (1) 154-161 10.1074/jbc.272.1.154
49. Wang, H.; Liao, S.; Geng, R. IGF-1 signaling via the PI3K/akt pathway confers neuroprotection in human retinal pigment epithelial cells exposed to sodium nitroprusside insult J. Mol. Neurosci. 2015, 55, 931-940 10.1007/s12031-014-0448-7
50. Weng, C. Y.; Kothary, P. C.; Verkade, A. J.; Reed, D. M.; Del Monte, M. A. MAP kinase pathway is involved in IGF-1-stimulated proliferation of human retinal pigment epithelial cells (hRPE) Curr. Eye Res. 2009, 34 (10) 867-876 10.3109/02713680903177890
51. Chaum, E.; Yang, H. T. Transgenic expression of IGF-1 modifies the proliferative potential of human retinal pigment epithelial cells Invest. Ophthalmol. Vis. Sci. 2002, 43 (12) 3758-3764
52. Barazi, H. O.; Zhou, L. G.; Templeton, N. S.; Krutzsch, H. C.; Roberts, D. D. Identification of heat shock protein 60 as a molecular mediator of alpha 3 beta 1 integrin activation Cancer Res. 2002, 62 (5) 1541-1548
53. Salani, B.; Briatore, L.; Contini, P. et al. IGF-I induced rapid recruitment of integrin beta(1) to lipid rafts is caveolin-1 dependent Biochem. Biophys. Res. Commun. 2009, 380 (3) 489-492 10.1016/j.bbrc.2009.01.102
54. Saegusa, J.; Yamaji, S.; Ieguchi, K. et al. The direct binding of insulin-like growth factor-1 (IGF-1) to integrin alpha v beta 3 is involved in IGF-1 signaling J. Biol. Chem. 2009, 284 (36) 24106-24114 10.1074/jbc.M109.013201
55. Fujita, M.; Ieguchi, K.; Davari, P. et al. Cross-talk between integrin alpha 6 beta 4 and insulin-like growth factor-1 receptor (IGF1R) through direct alpha 6 beta 4 binding to IGF1 and subsequent alpha 6 beta 4-IGF1-IGF1R ternary complex formation in anchorage-independent conditions J. Biol. Chem. 2012, 287 (15) 12491-12500 10.1074/jbc.M111.304170
56. Alfano, D.; Iaccarino, I.; Stoppelli, M. P. Urokinase signaling through its receptor protects against anoikis by increasing BCL-xL expression levels J. Biol. Chem. 2006, 281 (26) 17758-17767 10.1074/jbc.M601812200
57. Khwaja, A.; Rodriguez-Viciana, P.; Wennstrom, S.; Warne, P. H.; Downward, J. Matrix adhesion and ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/akt cellular survival pathway EMBO J. 1997, 16 (10) 2783-2793 10.1093/emboj/16.10.2783
58. Porstmann, T.; Griffiths, B.; Chung, Y. L. et al. PKB/akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP Oncogene 2005, 24 (43) 6465-6481 10.1038/sj.onc.1208802
59. Uebersax, E. D.; Grindstaff, R. D.; Defoe, D. M. Survival of the retinal pigment epithelium in vitro: Comparison of freshly isolated and subcultured cells Exp. Eye Res. 2000, 70 (3) 381-390 10.1006/exer.1999.0802
60. Han, S.; Ham, T. R.; Haque, S.; Sparks, J. L.; Saul, J. M. Alkylation of human hair keratin for tunable hydrogel erosion and drug delivery in tissue engineering applications Acta Biomater. 2015, 23, 201-213 10.1016/j.actbio.2015.05.013
61. Balcom, N. T.; Berg-Johansen, B.; Dills, K. J. et al. In vitro articular cartilage growth with sequential application of IGF-1 and TGF-beta 1 enhances volumetric growth and maintains compressive properties J. Biomech. Eng. 2012, 134 (3) 031001 10.1115/1.4005851
62. Florine, E. M.; Miller, R. E.; Liebesny, P. H. et al. Delivering heparin-binding insulin-like growth factor 1 with self-assembling peptide hydrogels Tissue Eng., Part A 2015, 21 (3-4) 637-646 10.1089/ten.tea.2013.0679
63. Ma, J.; Guo, C.; Guo, C. et al. Transplantation of human neural progenitor cells expressing IGF-1 enhances retinal ganglion cell survival PLoS One 2015, 10 (4) e0125695 10.1371/journal.pone.0125695
64. Kang, C. E.; Poon, P. C.; Tator, C. H.; Shoichet, M. S. A new paradigm for local and sustained release of therapeutic molecules to the injured spinal cord for neuroprotection and tissue repair Tissue Eng., Part A 2009, 15 (3) 595-604 10.1089/ten.tea.2007.0349
65. Phung, Y. T.; Barbone, D.; Broaddus, V. C.; Ho, M. Rapid generation of in vitro multicellular spheroids for the study of monoclonal antibody therapy J. Cancer 2011, 2, 507-514 10.7150/jca.2.507
66. Klimanskaya, I.; Hipp, J.; Rezai, K.; West, M.; Atala, A.; Lanza, R. Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics Cloning Stem Cells 2004, 6 (3) 217-245 10.1089/clo.2004.6.217
67. D'Esposito, V.; Passaretti, F.; Hammarstedt, A. et al. Adipocyte-released insulin-like growth factor-1 is regulated by glucose and fatty acids and controls breast cancer cell growth in vitro Diabetologia 2012, 55 (10) 2811-2822 10.1007/s00125-012-2629-7
68. Pacher, M.; Seewald, M. J.; Mikula, M. et al. Impact of constitutive IGF1/IGF2 stimulation on the transcriptional program of human breast cancer cells Carcinogenesis 2007, 28 (1) 49-59 10.1093/carcin/bgl091
69. Ritger, P. L.; Peppas, N. A. A simple equation for description of solute release I. fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs J. Controlled Release 1987, 5 (1) 23-36 10.1016/0168-3659(87)90034-4
70. Willerth, S. M.; Johnson, P. J.; Maxwell, D. J.; Parsons, S. R.; Doukas, M. E.; Sakiyama-Elbert, S. E. Rationally designed peptides for controlled release of nerve growth factor from fibrin matrices J. Biomed. Mater. Res., Part A 2007, 80A (1) 13-23 10.1002/jbm.a.30844
71. Jha, A. K.; Mathur, A.; Svedlund, F. L.; Ye, J.; Yeghiazarians, Y.; Healy, K. E. Molecular weight and concentration of heparin in hyaluronic acid-based matrices modulates growth factor retention kinetics and stem cell fate J. Controlled Release 2015, 209, 308-316 10.1016/j.jconrel.2015.04.034
72. Joung, Y. K.; Bae, J. W.; Park, K. D. Controlled release of heparin-binding growth factors using heparin-containing particulate systems for tissue regeneration Expert Opin. Drug Delivery 2008, 5 (11) 1173-1184 10.1517/17425240802431811
73. Vulic, K.; Pakulska, M. M.; Sonthalia, R.; Ramachandran, A.; Shoichet, M. S. Mathematical model accurately predicts protein release from an affinity-based delivery system J. Controlled Release 2015, 197, 69-77 10.1016/j.jconrel.2014.10.032
74. Vugler, A.; Carr, A.; Lawrence, J. et al. Elucidating the phenomenon of HESC-derived RPE: Anatomy of cell genesis, expansion and retinal transplantation Exp. Neurol. 2008, 214 (2) 347-361 10.1016/j.expneurol.2008.09.007
75. Trochon, V.; Mabilat, C.; Bertrand, P. et al. Evidence of involvement of CD44 in endothelial cell proliferation, migration and angiogenesis in vitro Int. J. Cancer 1996, 66 (5) 664-668 10.1002/(SICI)1097-0215(19960529)66:5<664::AID-IJC14>3.0.CO;2-4
76. Tsuneki, M.; Madri, J. A. CD44 regulation of endothelial cell proliferation and apoptosis via modulation of CD31 and VE-cadherin expression J. Biol. Chem. 2014, 289 (9) 5357-5370 10.1074/jbc.M113.529313
77. Stamenkovic, I.; Yu, Q. Merlin, a "magic" linker between the extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survival Curr. Protein Pept. Sci. 2010, 11 (6) 471-484 10.2174/138920310791824011
78. Bunek, J.; Kamarajan, P.; Kapila, Y. L. Anoikis mediators in oral squamous cell carcinoma Oral Dis. 2011, 17 (4) 355-361 10.1111/j.1601-0825.2010.01763.x
79. Liu, N. P.; Roberts, W. L.; Hale, L. P. et al. Expression of CD44 and variant isoforms in cultured human retinal pigment epithelial cells Invest. Ophthalmol. Vis. Sci. 1997, 38 (10) 2027-2037